Article
Loss of Tsc1 accelerates malignant gliomagenesis when combined with oncogenic signals.
Journal of biochemistry - 1 Apr 2014
Yamada Daisuke, Hoshii Takayuki, Tanaka Shingo, Hegazy Ahmed M, Kobayashi Masahiko, Tadokoro Yuko, Ohta Kumiko, Ueno Masaya, Ali Mohamed A E, Hirao Atsushi
Abstract excerpt
Glioblastomas frequently harbour genetic lesions that stimulate the activity of mammalian target of rapamycin complex 1 (mTORC1). Loss of heterozygosity of tuberous sclerosis complex 1 (TSC1) or TSC2, which together form a critical negative regulator of mTORC1, is also seen in glioblastoma; however, it is not known how loss of the TSC complex affects the development of malignant gliomas. Here we investigated the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
